United States Patient At Home Testing Kits Market to Grow with a CAGR of 7.94% until 2026
Growing adoption of DIY
(Do-it-Yourself) testing and diagnostics concept is expected to drive the
growth of United States patient at home testing kits market.
According to TechSci report on, “United
States Patient At Home Testing Kits Market By Test Type (Blood Glucose
Testing, Pregnancy & Fertility Testing, Cholesterol Testing, Urine Testing,
COVID-19 Testing, Others), By Sample (Blood, Urine, Saliva), By Usage
(Disposable v/s Reusable), By Distribution Channel (Retail Pharmacy Stores,
Hypermarket/Supermarket, E-Commerce) By Region, Competition Forecast &
Opportunities, 2026”, United States patient at home testing kits market stood
at USD3239.54 million and is expected to grow at a CAGR of 7.94% during the
forecast period. The growing healthcare awareness among the population about
the prevalence, causes, symptoms, diagnosis and treatment of different diseases
is expected to fuel the growth of the United States patient at home testing
kits market.
The population in the country has become quite
conscious and aware about different diseases and a paradigm shift has been
observed in the behavior of the general population towards preventive healthcare
rather than curative healthcare. This will certainly increase the demand for at
home testing kits in the coming years. Additionally, the growing prevalence of
chronic diseases such as cardiovascular diseases and diabetes is expected to
support the market growth through 2026. United States is home to the world’s
third largest diabetic population. Around 30.3 million adults in the United
States are suffering from diabetes which is almost 1 in 10 adults.
Cardiovascular diseases are the leading cause of death in the United States,
with around 659,041 reported deaths in 2019.
The major factors contributing to cardiovascular
diseases in the United States are diabetes and high cholesterol. This in turn
is expected to increase the demand for blood glucose testing and cholesterol
testing segment of patient at home testing kits market. However, it has been
observed that although the patient at home testing kits are convenient, easy to
use and deliver rapid results but sometimes the results of these tests are not correct,
i.e., the diagnosis done by these testing kits is not correct. This is very
commonly observed in case of pregnancy/fertility testing kits wherein false
positive or false negative results are generated. This in turn leads to
reliability constraints among the users and they prefer going to the doctor at
early stages only rather than taking self-tests at home.
Browse over 25
market data Figures and 2 data Tables spread through 84
Pages and an in-depth TOC on "United States Patient At Home Testing
Kits Market"
https://www.techsciresearch.com/report/united-states-patient-at-home-testing-kits-market/7556.html
United
States patient at home testing kits market can be segmented into test type,
sample, usage, distribution channel, region and company. Based on sample, the
United States patient at home testing kits market can be categorized into
blood, urine and saliva. The blood sample segment dominated the market in 2020
with a share of around 44.50% and will continue to maintain its dominance in
the forecast period as well since blood samples are used to perform majority of
patient at home diagnostic tests including blood glucose monitoring, HIV
testing, prothrombin test, among others. However, the share for saliva
significantly increased in 2021 on account of their widespread use in at home
COVID-19 testing.
While
the urine samples are majorly used in pregnancy/fertility testing and urine
analysis. By usage, the United
States patient at home testing kits market can be segmented into disposable
kits and reusable kits. Disposable kits hold a larger share in the patient at
home testing kit market and will continue to grow in the forecast period. The
reason for the uninterrupted demand for disposable kit will directly depend on
their consumer behavior. Most of the self- diagnostic tests, which primarily
include sources like saliva, urine testing which require disposable kits.
Moreover, increasing awareness regarding health and hygiene after COVID-19
outbreak is one of the leading factors to use disposable kits, only to prevent
the further spread of infection. Diagnostic tests done by reusable kits are
disease specific and require more attention while handling as compared to
disposable kits.
Major
players operating in the United States patient at home testing kits market
include Lucira Health Inc., Essenlix Corporation, Abbott Laboratories, Inc.,
Roche Diagnostics Corporation, Siemens Medical Solutions USA, Inc., Thermo
Fischer Scientific, Inc., Scanwell Health, Inc., Quidel Corporation, GE
Healthcare, Inc., ACON Laboratories, Inc., among others.
Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=7556
Customers can also request for 10% free
customization on this report.
“The
growing adoption of telemedicine and remote patient monitoring in the United
States has significantly increased the demand for patient at home testing kits.
Additional advancements such as use of digital pregnancy kits, pregnancy strip
self-test, among others are further expected to support the market growth
through 2026.,” said Mr. Karan Chechi, Research Director with TechSci Research,
a research based global management consulting firm.
“United
States Patient At Home Testing Kits Market By Test Type (Blood Glucose Testing,
Pregnancy & Fertility Testing, Cholesterol Testing, Urine Testing, COVID-19
Testing, Others), By Sample (Blood, Urine, Saliva), By Usage (Disposable v/s
Reusable), By Distribution Channel (Retail Pharmacy Stores,
Hypermarket/Supermarket, E-Commerce) By Region, Competition Forecast &
Opportunities, 2026” has evaluated the
future growth potential of United States patient at home testing kits market
and provides statistics & information on market size, structure and future
market growth. The report intends to provide cutting-edge market intelligence
and help decision makers take sound investment decisions. Besides, the report
also identifies and analyzes the emerging trends along with essential drivers, challenges,
and opportunities in United States patient at home testing kits market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel:
+1-646-360-1656
Email: [email protected]
Website: https://www.techsciresearch.com/